Logo image of ACTU

ACTUATE THERAPEUTICS INC (ACTU) Stock Earnings & Estimates

NASDAQ:ACTU - US0050831009 - Common Stock

8.05 USD
-0.14 (-1.71%)
Last: 8/27/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
ACTU revenue by date.ACTU revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
ACTU ebitda by date.ACTU ebitda by date.
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ACTU ebit by date.ACTU ebit by date.
-20.207M-24.974M
-23.59%
-25.161M
-0.75%
N/A
-11.62%
N/A
-36.74%
N/A
-53.52%
Operating Margin
ACTU operating margin by date.ACTU operating margin by date.
N/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ACTU eps by date.ACTU eps by date.
N/AN/AN/AN/A
64.14%
N/A
-16.18%
N/A
-29.11%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.28-0.27
17.57%
-0.31
2.78%
-0.31
-0.35%
-0.33
-18.52%
-0.34
-25.62%
-0.43
-37.70%
-0.45
-44.26%
-0.47
-43.75%
-0.48
-40.30%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-6.264M
-16.16%
-6.462M
1.47%
-8.16M
-28.19%
-8.67M
-45.25%
-9.18M
-46.55%
-9.69M
-49.94%
-10.2M
-25.00%
-10.302M
-18.82%
-10.817M
-17.83%
-11.73M
-21.05%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.31 -0.320.013.52%
Q1 2025
Q2Q % growth
-0.32 -0.31-0.01-3.43%
Q4 2024
Q2Q % growth
-0.33 -0.30-0.03-11.56%
ACTU Yearly EPS VS EstimatesACTU Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -1 -2 -3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS10% N/A 9.69% 0.87%
RevenueN/A N/A N/A N/A